Publications found:
51,015
Sort by:
Glass Tube Market in United States to 2017 - Market Size, Trends, and Forecasts
US$ 653.00
... until 2017 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for ... KEY QUESTIONS SUCH AS: What is the size of the glass tube market in United States? How is the market divided into different product segments? ...
August 2013
15 pages
Dolomite Market in United States to 2017 - Market Size, Trends, and Forecasts
US$ 653.00
... until 2017 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for ... KEY QUESTIONS SUCH AS: What is the size of the dolomite market in United States? How is the market divided into different product segments? Which ...
August 2013
13 pages
Merck – One timers and Forex weigh on Merck’s guidance
US$ 90.00
MRK reported its 2Q 2013 results: the net sales decline by 11% ($11.0b) including negative foreign exchange impact by 3% compared to last year. Company reiterated its 2013 non-GAAP EPS guidance ($3.45 and $3.55) while revised its GAAP EPS to be between $1.84 and $2.05 (previous $1.92-2.16). MRK expects its ...
August 2013
1 pages
Wood Based Panel Market in United States to 2017 - Market Size, Trends, and Forecasts
US$ 653.00
... until 2017 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for ... QUESTIONS SUCH AS: What is the size of the wood based panel market in United States? How is the market divided into different product segments? ...
July 2013
22 pages
Merck -Suvorexant delayed but no additional studies required is a sigh of relief
US$ 90.00
FDA recently issued a complete response letter to MRK’s Suvorexant. As per the complete response letter, the USFDA will need ... not be approved. We see the launch timelines delayed by atleast 12 to 18 months. In case of the 10mg dose Merck would have to conduct an additional stability study ...
July 2013
1 pages
United States (USA) Online Retail, E-Retail, E-Tailing Market & Forecast - By Merchandise, Payment Method, & 22 Companies Analysis to 2017
US$ 1,400.00
... any other ecommerce product segment and the category is poised to help US retail ecommerce sales grow. Today, the biggest driver of growth in the ... -and-mortar operations. Renub Research study titled “United States (USA) Online Retail, E-Retail, E-Tailing Market & Forecast - By Merchandise, Payment Method, ...
July 2013
178 pages
Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
US$ 3,600.00
This new 278-page report from Venture Planning Group provides analysis of the US sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed ...
June 2013
278 pages
Analysis of the Enteric Disease Testing Market in the US: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus,Rotavirus, Salmonella, Shigella, Vibrio, Yersinia
US$ 4,320.00
... suppliers. About this Report This report presents detailed analysis of the Enteric Disease market in the US. Current scientific views on epidemiology and ... presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by tests. Also, the report: Examines market ...
June 2013
314 pages
Analysis of the Respiratory Disease Testing Market in the US: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
US$ 3,680.00
... by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in the US. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, ...
June 2013
282 pages
2013 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices--Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
US$ 3,120.00
The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, ...
June 2013
241 pages
2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices
US$ 2,800.00
... for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Drugs of Abuse Testing in the US: Hospitals, Commercial Labs, Physician Offices” is a unique study designed to help current suppliers and potential market ...
June 2013
262 pages
2013 Endocrine Function Testing Market in the US: Hospitals, Commercial Labs, Physician Offices
US$ 2,800.00
... new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “2013 Endocrine Function Testing Market in the US: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers ...
June 2013
271 pages
Acorda Therapeutics - Pipeline and Label Expansion of AMPYRA- Drivers of Growth
US$ 140.00
Stable sales from marketed products, maturing pipeline and focus on targeting unmet needs in CNS diseases- Acorda (ACOR) has not disappointed its investors ... detail, please read our report released on June 06, 2013, titled, “Acorda Therapeutics - Pipeline and Label Expansion of AMPYRA- Drivers of Growth”.
June 2013
3 pages
2013 Immunoprotein Diagnostic Testing in the US: Hospitals, Commercial Labs, Physician Offices
US$ 2,800.00
... of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. “Immunoprotein Diagnostic Testing in the US: Hospitals, Commercial Labs, Physician Offices” is a unique market and technology assessment designed to help current suppliers and ...
June 2013
236 pages
US Non-Invasive Prenatal Diagnostics - Market Insight
US$ 1,200.00
... pose serious risks of miscarriages and are being replaced by the non-invasive prenatal diagnostics technologies. Although NIPD is a relatively nascent segment of the ... and early diagnosis. Products such as MaterniT21 Plus, Verifi, and Harmony prenatal tests are the current tests available in the market. Around ...
June 2013
60 pages
US Nutraceuticals Market Forecast to 2017
US$ 1,000.00
... growth. In RNCOS’ latest research study, “US Nutraceuticals Market Forecast to 2017”, RNCOS analysts identified and deciphered the market dynamics in important segments to clearly ... the reader to gain a deeper insight into each key market player. Moreover, market drivers and trends have been discussed along ...
June 2013
100 pages
2013 Analysis of the US Point-of-Care Clinical Chemistry Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major clinical chemistry reagent and ...
May 2013
373 pages
2013 Analysis of the US Point-of-Care Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major coagulation reagent and instrument ...
May 2013
418 pages
2013 Analysis of the US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major hematology and flow cytometry ...
May 2013
238 pages
2013 Analysis of the US PT and APTT Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 2,320.00
... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers. ...
May 2013
337 pages
POC Lipid Testing Market in the US: Physician Offices, Emergency Rooms, Ambulatory Care Centers
US$ 2,320.00
... Planning Group contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, ... for new instruments and reagent systems with potentially significant market appeal during the next five years. Design criteria for ...
May 2013
305 pages
2013 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers
US$ 4,400.00
... and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...
May 2013
795 pages
Competing in the US Point-of-Care Diagnostic Testing Market
US$ 13,200.00
... market segment: Home/Personal Testing Physician Offices/Group Practices Emergency Rooms Operating/Recovery Suites ICUs/CCUs Cancer Clinics Ambulatory Care Centers Surgery Centers Nursing Homes Birth Centers and by test category: Routine and Special Chemistry Microbiology/Infectious Diseases ...
May 2013
1172 pages
Diagnostic Testing in the US Ancillary Hospital Locations (ER, OR, ICU)
US$ 10,000.00
... among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient. Market Segmentation Analysis ... during the next ten years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers ...
May 2013
973 pages
ASCO ‘13 - Promise of Novel Targets/Technologies to Unfold At ASCO 2013
US$ 140.00
... / BiTE) for Hematological Malignancies and Solid tumors will be highlighted at ASCO. These include Amgen’s T-VEC (PhIII), Blinatumomab (PhII/III); Gilead ... detail, please read our report released on May 29, 2013, titled, “ASCO ‘13 - Promise of Novel Targets/Technologies to Unfold ...
May 2013
12 pages
Tobacco Products - United States
US$ 653.00
... the actual market situation, trends and future outlook for tobacco products in United States. The study provides essential market information for decision ... potential for the market? How the macroeconomic indicators look like? Product types discussed in the study: Cigarettes Cigars, cigarillos and cheroots ...
May 2013
22 pages
